BIOMAT Database Logo BIOMAT Database Logo

Serum tumor necrosis factor-alpha and interleukin-6 levels in neonatal sepsis. 2003

Selim Kurtogglu, and Hüseyin Caksen, and Ibrahim Kurtulus Hallaç, and Hasan Basri Ustünbas, and Kazim Uzüm, and Hüseyin Kiliç

UI MeSH Term Description Entries
D007231 Infant, Newborn An infant during the first 28 days after birth. Neonate,Newborns,Infants, Newborn,Neonates,Newborn,Newborn Infant,Newborn Infants
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D014409 Tumor Necrosis Factor-alpha Serum glycoprotein produced by activated MACROPHAGES and other mammalian MONONUCLEAR LEUKOCYTES. It has necrotizing activity against tumor cell lines and increases ability to reject tumor transplants. Also known as TNF-alpha, it is only 30% homologous to TNF-beta (LYMPHOTOXIN), but they share TNF RECEPTORS. Cachectin,TNF-alpha,Tumor Necrosis Factor Ligand Superfamily Member 2,Cachectin-Tumor Necrosis Factor,TNF Superfamily, Member 2,TNFalpha,Tumor Necrosis Factor,Cachectin Tumor Necrosis Factor,Tumor Necrosis Factor alpha
D015415 Biomarkers Measurable and quantifiable biological parameters (e.g., specific enzyme concentration, specific hormone concentration, specific gene phenotype distribution in a population, presence of biological substances) which serve as indices for health- and physiology-related assessments, such as disease risk, psychiatric disorders, ENVIRONMENTAL EXPOSURE and its effects, disease diagnosis; METABOLIC PROCESSES; SUBSTANCE ABUSE; PREGNANCY; cell line development; EPIDEMIOLOGIC STUDIES; etc. Biochemical Markers,Biological Markers,Biomarker,Clinical Markers,Immunologic Markers,Laboratory Markers,Markers, Biochemical,Markers, Biological,Markers, Clinical,Markers, Immunologic,Markers, Laboratory,Markers, Serum,Markers, Surrogate,Markers, Viral,Serum Markers,Surrogate Markers,Viral Markers,Biochemical Marker,Biologic Marker,Biologic Markers,Clinical Marker,Immune Marker,Immune Markers,Immunologic Marker,Laboratory Marker,Marker, Biochemical,Marker, Biological,Marker, Clinical,Marker, Immunologic,Marker, Laboratory,Marker, Serum,Marker, Surrogate,Serum Marker,Surrogate End Point,Surrogate End Points,Surrogate Endpoint,Surrogate Endpoints,Surrogate Marker,Viral Marker,Biological Marker,End Point, Surrogate,End Points, Surrogate,Endpoint, Surrogate,Endpoints, Surrogate,Marker, Biologic,Marker, Immune,Marker, Viral,Markers, Biologic,Markers, Immune
D015850 Interleukin-6 A cytokine that stimulates the growth and differentiation of B-LYMPHOCYTES and is also a growth factor for HYBRIDOMAS and plasmacytomas. It is produced by many different cells including T-LYMPHOCYTES; MONOCYTES; and FIBROBLASTS. Hepatocyte-Stimulating Factor,Hybridoma Growth Factor,IL-6,MGI-2,Myeloid Differentiation-Inducing Protein,Plasmacytoma Growth Factor,B Cell Stimulatory Factor-2,B-Cell Differentiation Factor,B-Cell Differentiation Factor-2,B-Cell Stimulatory Factor 2,B-Cell Stimulatory Factor-2,BSF-2,Differentiation Factor, B-Cell,Differentiation Factor-2, B-Cell,IFN-beta 2,IL6,Interferon beta-2,B Cell Differentiation Factor,B Cell Differentiation Factor 2,B Cell Stimulatory Factor 2,Differentiation Factor 2, B Cell,Differentiation Factor, B Cell,Differentiation-Inducing Protein, Myeloid,Growth Factor, Hybridoma,Growth Factor, Plasmacytoma,Hepatocyte Stimulating Factor,Interferon beta 2,Interleukin 6,Myeloid Differentiation Inducing Protein,beta-2, Interferon
D016022 Case-Control Studies Comparisons that start with the identification of persons with the disease or outcome of interest and a control (comparison, referent) group without the disease or outcome of interest. The relationship of an attribute is examined by comparing both groups with regard to the frequency or levels of outcome over time. Case-Base Studies,Case-Comparison Studies,Case-Referent Studies,Matched Case-Control Studies,Nested Case-Control Studies,Case Control Studies,Case-Compeer Studies,Case-Referrent Studies,Case Base Studies,Case Comparison Studies,Case Control Study,Case Referent Studies,Case Referrent Studies,Case-Comparison Study,Case-Control Studies, Matched,Case-Control Studies, Nested,Case-Control Study,Case-Control Study, Matched,Case-Control Study, Nested,Case-Referent Study,Case-Referrent Study,Matched Case Control Studies,Matched Case-Control Study,Nested Case Control Studies,Nested Case-Control Study,Studies, Case Control,Studies, Case-Base,Studies, Case-Comparison,Studies, Case-Compeer,Studies, Case-Control,Studies, Case-Referent,Studies, Case-Referrent,Studies, Matched Case-Control,Studies, Nested Case-Control,Study, Case Control,Study, Case-Comparison,Study, Case-Control,Study, Case-Referent,Study, Case-Referrent,Study, Matched Case-Control,Study, Nested Case-Control
D017741 Survivors Persons who have experienced a prolonged survival after serious disease or who continue to live with a usually life-threatening condition as well as family members, significant others, or individuals surviving traumatic life events. Long-Term Survivors,Long Term Survivors,Long-Term Survivor,Survivor,Survivor, Long-Term,Survivors, Long-Term
D018805 Sepsis Systemic inflammatory response syndrome with a proven or suspected infectious etiology. When sepsis is associated with organ dysfunction distant from the site of infection, it is called severe sepsis. When sepsis is accompanied by HYPOTENSION despite adequate fluid infusion, it is called SEPTIC SHOCK. Bloodstream Infection,Pyaemia,Pyemia,Pyohemia,Blood Poisoning,Poisoning, Blood,Septicemia,Severe Sepsis,Blood Poisonings,Bloodstream Infections,Infection, Bloodstream,Poisonings, Blood,Pyaemias,Pyemias,Pyohemias,Sepsis, Severe,Septicemias

Related Publications

Selim Kurtogglu, and Hüseyin Caksen, and Ibrahim Kurtulus Hallaç, and Hasan Basri Ustünbas, and Kazim Uzüm, and Hüseyin Kiliç
Tumor necrosis factor-alpha, interleukin-1 beta, and interleukin-6 plasma levels in neonatal sepsis.
April 1993, Pediatric research,
Selim Kurtogglu, and Hüseyin Caksen, and Ibrahim Kurtulus Hallaç, and Hasan Basri Ustünbas, and Kazim Uzüm, and Hüseyin Kiliç
Serum leptin levels and their relationship to tumor necrosis factor-alpha and interleukin-6 in neonatal sepsis.
December 2003, Journal of pediatric endocrinology & metabolism : JPEM,
Selim Kurtogglu, and Hüseyin Caksen, and Ibrahim Kurtulus Hallaç, and Hasan Basri Ustünbas, and Kazim Uzüm, and Hüseyin Kiliç
Serum concentrations of interleukin-1 alpha, interleukin-6 and tumor necrosis factor-alpha in neonatal sepsis and meningitis.
October 2006, Saudi medical journal,
Selim Kurtogglu, and Hüseyin Caksen, and Ibrahim Kurtulus Hallaç, and Hasan Basri Ustünbas, and Kazim Uzüm, and Hüseyin Kiliç
Effect of pentoxifylline on tumor necrosis factor-alpha and interleukin-6 levels in neonatal sepsis.
August 2004, The Medical journal of Malaysia,
Selim Kurtogglu, and Hüseyin Caksen, and Ibrahim Kurtulus Hallaç, and Hasan Basri Ustünbas, and Kazim Uzüm, and Hüseyin Kiliç
Serum tumor necrosis factor-alpha in neonatal sepsis.
August 1997, American journal of perinatology,
Selim Kurtogglu, and Hüseyin Caksen, and Ibrahim Kurtulus Hallaç, and Hasan Basri Ustünbas, and Kazim Uzüm, and Hüseyin Kiliç
Serum amyloid A, procalcitonin, tumor necrosis factor-alpha, and interleukin-1beta levels in neonatal late-onset sepsis.
January 2008, Mediators of inflammation,
Selim Kurtogglu, and Hüseyin Caksen, and Ibrahim Kurtulus Hallaç, and Hasan Basri Ustünbas, and Kazim Uzüm, and Hüseyin Kiliç
Interleukin-1alpha, interleukin-6 and tumor necrosis factor-alpha levels in children with sepsis and meningitis.
April 2006, Pediatrics international : official journal of the Japan Pediatric Society,
Selim Kurtogglu, and Hüseyin Caksen, and Ibrahim Kurtulus Hallaç, and Hasan Basri Ustünbas, and Kazim Uzüm, and Hüseyin Kiliç
Tumor necrosis factor alpha and interleukin 6 in infants with sepsis.
October 2005, Indian pediatrics,
Selim Kurtogglu, and Hüseyin Caksen, and Ibrahim Kurtulus Hallaç, and Hasan Basri Ustünbas, and Kazim Uzüm, and Hüseyin Kiliç
Serum levels of tumor necrosis factor-alpha and interleukin-6 in ocular cicatricial pemphigoid.
December 1993, Investigative ophthalmology & visual science,
Selim Kurtogglu, and Hüseyin Caksen, and Ibrahim Kurtulus Hallaç, and Hasan Basri Ustünbas, and Kazim Uzüm, and Hüseyin Kiliç
Serum levels of proinflammatory cytokines interleukin-1beta, interleukin-6, and tumor necrosis factor alpha in mixed cryoglobulinemia.
December 2009, Arthritis and rheumatism,
Copied contents to your clipboard!